Free shipping on all orders over $ 500

CRX-527

Cat. No. M10331

All AbMole products are for research use only, cannot be used for human consumption.

CRX-527 Structure
Synonym:

CRX527

Size Price Availability
1mg USD 450  USD450 Custom Synthesis
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

CRX-527 is a highly specific and potent TLR4 agonist, which displays significantly less toxicity when compared to LPS. CRX-527 activates Toll-like receptor 4 (TLR4). Subsequently, it initiates MyD88- and TRIF-dependent pro-inflammatory signaling cascades. Importantly, CRX-527 does not require the TLR4 co-receptor CD14 for activation of either signaling pathway. CRX-527, along with other AGPs, is less toxic than LPS and importantly retains its immunostimulatory properties.

Chemical Information
Molecular Weight 1488.04
Formula C81H151N2O19P
CAS Number 216014-14-1
Solubility (25°C) DMSO 1 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Amandine Legat, et al. Eur J Immunol. CD14-independent responses induced by a synthetic lipid A mimetic

[2] Axel G Stover, et al. J Biol Chem. Structure-activity relationship of synthetic toll-like receptor 4 agonists

[3] Zi Yan Tan, et al. Open J Immunol. Synthetic TLR4 agonist as a potential immunotherapy for melioidosis

Related TLR Products
Pepinh-TRIF TFA

Pepinh-TRIF TFA blocks TIR-domain-containing adapter-inducing interferon-β (TRIF) signaling by interfering with TLR-TRIF interaction.

CAY10614

CAY10614 is a potent TLR4 antagonist. CAY10614 inhibits the lipid A-induced activation of TLR4, with an IC50 of 1.675 μM.

TLR4-IN-C34-C2-COOH

TLR4-IN-C34-C2-COO is a linker that incorporates TLR4 inhibitor TLR4-IN-C34. TLR4-IN-C34 inhibits TLR4 in enterocytes and macrophages, and reduces systemic inflammation in mouse models of endotoxemia and necrotizing enterocolitis.

BNT411 

BNT411 is a selective TLR7 agonist that can induce the release of IFNa both in vivo and in vitro.

Rabeximod

Rabeximod (ROB-803), an anti-rheumatic compound, impairs the differentiation and function of human pro-inflammatory dendritic cells and macrophages via downregulating TLR2 and TLR4 stimulation.

  Catalog
Abmole Inhibitor Catalog




Keywords: CRX-527, CRX527 supplier, TLR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.